138 related articles for article (PubMed ID: 29878670)
1. Session 4: Shaping radiotherapy for rectal cancer: should this be personalized?
Dattani M; Marijnen C; Moran B; Tait D; Cunningham C; Rodriguez-Bigas M; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():92-96. PubMed ID: 29878670
[TBL] [Abstract][Full Text] [Related]
2. Session 3: Boosting primary and recurrent rectal cancer: how far can we push the radiotherapy envelope?
Balyasnikova S; Vuong T; Wale A; Chong I; Rutten H; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():88-91. PubMed ID: 29878674
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice.
Fitzgerald TL; Biswas T; O'Brien K; Zervos EE; Wong JH
World J Surg; 2013 Mar; 37(3):639-45. PubMed ID: 23224073
[TBL] [Abstract][Full Text] [Related]
4. Session 3: Beyond TME and radiotherapy MRI evaluation of rectal cancer treatment response.
Patel UB; Blomqvist L; Chau I; Nicholls J; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():76-81. PubMed ID: 29878685
[TBL] [Abstract][Full Text] [Related]
5. Preoperative neo-adjuvant therapy for curable rectal cancer--reaching a consensus 2008.
Scott NA; Susnerwala S; Gollins S; Myint AS; Levine E
Colorectal Dis; 2009 Mar; 11(3):245-8. PubMed ID: 18637934
[TBL] [Abstract][Full Text] [Related]
6. Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.
Korkolis DP; Plataniotis GD; Gondikakis E; Xinopoulos D; Koulaxouzidis GV; Katsilieris J; Vassilopoulos PP
Int J Colorectal Dis; 2006 Jan; 21(1):1-6. PubMed ID: 15947936
[TBL] [Abstract][Full Text] [Related]
7. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
[TBL] [Abstract][Full Text] [Related]
8. Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?
Bhoday J; Glimelius B; Tait D; Glynne-Jones R; Adams R; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():97-99. PubMed ID: 29878687
[TBL] [Abstract][Full Text] [Related]
9. Session 4: Trying to augment response with chemotherapy: a triumph of hope over experience?
Battersby NJ; Perez RO; Baxter N; Moran B; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():100-102. PubMed ID: 29878682
[TBL] [Abstract][Full Text] [Related]
10. A nationwide audit of the use of radiotherapy for rectal cancer in Italy.
Gagliardi G; Pucciarelli S; Asteria CR; Infantino A; Romano G; Cola B; De Nardi P; Brulatti M; Lambertini M; Contessini-Avesani E; Casula G; Coco C; D'Amico D; Selvaggi FF; Eccher C; D'Ambrosio G; Galeotti F; Jovine E; Demma I; Fianchini A; Ambrosino G; Casentino LM; Fiorino M
Tech Coloproctol; 2010 Sep; 14(3):229-35. PubMed ID: 20632061
[TBL] [Abstract][Full Text] [Related]
11. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
12. Five fractions of preoperative radiotherapy for selected cases of rectal cancer.
Pistevou-Gompaki K
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s36-8. PubMed ID: 15655637
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Radiotherapy Versus No Radiotherapy for Stage IV Rectal Cancer: a Systematic Review and Meta-analysis.
Agas RAF; Co LBA; Jacinto JCKM; Yu KKL; Sogono PG; Bacorro WR; Sy Ortin TT
J Gastrointest Cancer; 2018 Dec; 49(4):389-401. PubMed ID: 30043227
[TBL] [Abstract][Full Text] [Related]
14. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
[TBL] [Abstract][Full Text] [Related]
15. A systematic overview of radiation therapy effects in rectal cancer.
Glimelius B; Grönberg H; Järhult J; Wallgren A; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):476-92. PubMed ID: 14596508
[TBL] [Abstract][Full Text] [Related]
16. Session 2: Are we ready for primary chemotherapy in rectal cancer: who, when, why?
Patel UB; Cervantes A; Fernández-Martos C; Sclafani F; Cunningham D; Nilsson P; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():56-60. PubMed ID: 29878678
[TBL] [Abstract][Full Text] [Related]
17. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
20. Session 3: Intra-operative radiotherapy - creating new surgical boundaries.
Patel A; Chang G; Wale A; Chong I; Rutten H; Nicholls J; Hawkins M; Steele RJC; Marks J; Brown G
Colorectal Dis; 2018 May; 20 Suppl 1():65-75. PubMed ID: 29878668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
